Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-13-000798
Filing Date
2013-05-15
Accepted
2013-05-15 13:14:50
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMCEUTICAL COMPANY, INC. 10Q 2013-03-31 aoxing.htm 10-Q 583332
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh311.htm EX-31.1 9382
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh312.htm EX-31.2 9077
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh321.htm EX-32.1 5379
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh322.htm EX-32.2 5440
  Complete submission text file 0001096906-13-000798.txt   3107726

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT* axn-20130331.xml EX-101.INS 409723
7 XBRL SCHEMA DOCUMENT* axn-20130331.xsd EX-101.SCH 31576
8 XBRL CALCULATION LINKBASE DOCUMENT* axn-20130331_cal.xml EX-101.CAL 24122
9 XBRL DEFINITION LINKBASE DOCUMENT* axn-20130331_def.xml EX-101.DEF 20349
10 XBRL LABELS LINKBASE DOCUMENT* axn-20130331_lab.xml EX-101.LAB 151326
11 XBRL PRESENTATION LINKBASE DOCUMENT* axn-20130331_pre.xml EX-101.PRE 125477
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 13845353
SIC: 2834 Pharmaceutical Preparations